JACOB A ORVILLE
CIK 1263312 · Senior Vice President · last filed 2026-03-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.78M
Companies
2
Total Filings
40
Lifetime Open-Market Net
-$3.29M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABT | Senior Vice President | 50,493 | $114.38 | $5.78M | $0 | 1 | 2026-03-25 |
| EXACT SCIENCES CORP (EXAS) Delisted | EVP, GM, Screening | 0 | $104.91 | $0 | -$3.29M | 31 | 2026-03-23 |
Recent Filings · Page 4 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-01 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-25 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +5,480 | -$330.7K | EDGAR |
| 2022-02-24 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +1,122 | -$77.7K | EDGAR |
| 2022-02-23 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +1,900 | $143.3K | EDGAR |
| 2022-02-16 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +1,090 | $84.2K | EDGAR |
| 2021-02-23 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-22 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +1,953 | -$243.2K | EDGAR |
| 2021-02-18 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +997 | -$147.4K | EDGAR |
| 2020-02-20 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +2,495 | -$116.1K | EDGAR |
| 2020-02-18 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–40 of 40
Prev
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.